AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Ravi Salgia

Ravi Salgia

Beckman Research Institute of City of Hope - California / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4613634
City of Hope National Medical Center
person_outline Ravi Salgia's MOST POPULAR ARTICLES
1-) Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer New England Journal of Medicine 363 (18), 1693-1703, 2010
2-) First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer New England Journal of Medicine 371 (23), 2167-2177, 2014
3-) Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer New England Journal of Medicine 371 (21), 1963-1971, 2014
4-) Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study The lancet oncology 13 (10), 1011-1019, 2012
5-) Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations Journal for immunotherapy of cancer 6 (1), 8, 2018